View:
Download DOC
Download PDF
Download XLS
SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Cribbs Eric
(Last) (First) (Middle)
5960 BERKSHIRE LN
SUITE 800
(Street)
DALLAS TX 75225
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/05/2022 		3. Issuer Name and Ticker or Trading Symbol
EAGLE MATERIALS INC [ EXP ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 16,039(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy) (2) 05/17/2028 Common Stock 791 106.24 D
Non-Qualified Stock Option (Right to Buy) (3) 05/17/2028 Common Stock 735 106.24 D
Non-Qualified Stock Option (Right to Buy) (4) 05/16/2029 Common Stock 4,824 91.58 D
Non-Qualified Stock Option (Right to Buy) (5) 05/16/2029 Common Stock 4,568 91.58 D
Non-Qualified Stock Option (Right to Buy) (6) 05/19/2030 Common Stock 2,292 60.21 D
Non-Qualified Stock Option (Right to Buy) (7) 05/19/2030 Common Stock 1,911 60.21 D
Explanation of Responses:
1. This number includes the following restricted shares: (a) 701 shares remaining from a grant awarded to the reporting person on 5/16/2019, the restrictions on which will lapse on 3/31/2023; (b) 3,083 shares remaining from a grant awarded to the reporting person on 5/19/2020, the restrictions on which will lapse ratably on March 31 of 2023 and 2024; (c) 2,666 shares remaining from a grant awarded to the reporting person on 5/19/2021, the restrictions on which will lapse ratably on March 31 of 2023, 2024 and 2025; and (d) 1,783 shares awarded to the reporting person on 5/19/2022, the restrictions on which will lapse ratably on March 31 of 2023, 2024, 2025 and 2026.
2. On May 17, 2018, the reporting person was granted an option to purchase up to 3,528 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2019. On May 13, 2019, the performance conditions were determined to have been satisfied such that stock options vested as to 3,165 shares, 791 of which remain exercisable.
3. On May 17, 2018 the reporting person was granted an option to purchase up to 2,940 shares of Common Stock, and currently 735 of these options remain exercisable.
4. On May 16, 2019, the reporting person was granted an option to purchase up to 5,481 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2020. On May 4, 2020, the performance conditions were determined to have been satisfied such that stock options vested as to 4,824 shares. Currently 3,618 options are exercisable and the remaining options vest on March 31, 2023.
5. On May 16, 2019 the reporting person was granted an option to purchase up to 4,568 shares of Common Stock. Currently 3,426 options are exercisable and the remaining options will vest on March 31, 2023.
6. On May 19, 2020, the reporting person was granted an option to purchase up to 3,057 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2021. On May 6, 2021, the performance conditions were determined to have been satisfied such that stock options vested as to 3,057 shares. Currently 764 options are exercisable and the remaining options vest on March 31 of 2023 and 2024.
7. On May 19, 2020 the reporting person was granted an option to purchase up to 2,548 shares of Common Stock. Currently 637 options are exercisable and the remaining options will vest ratably on March 31 of 2023 and 2024.
Remarks:
/s/ Scott M. Wilson as Attorney-in-Fact for Eric Cribbs 08/15/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
	Know all by these presents, that the undersigned hereby constitutes and
appoints each of Matt Newby, Scott M. Wilson and Alex Poor, or any of them
signing singly, and with full power of substitution, the undersigned's true and
lawful attorney-in-fact to:
	(1)	prepare, execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer and/or director of Eagle Materials Inc., a Delaware
corporation (the "Company"), (a) Forms 3, 4, and 5 in accordance with Section
16(a) of the Securities Exchange Act of 1934 and the rules thereunder; and (b)
Form 144 pursuant to Rule 144 under the Securities Act of 1933 (as amended) and
the rules thereunder;
	(2)	do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4 or 5,
or Form 144, complete and execute any amendment or amendments thereto, and
timely file such form with the SEC and any stock exchange or similar authority;
and
	(3)	take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Limited Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact may approve in
such attorney-in-fact's discretion.
	The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Limited Power of Attorney and the rights and powers
herein granted.  The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934 or Rule 144.
	This Limited Power of Attorney supersedes any Section 16 power of attorney
previously granted by the undersigned with respect to the undersigned's holdings
of and transactions in securities issued by the Company and shall remain in full
force and effect until the undersigned is no longer required to file Forms 3, 4,
and 5 and Form 144 with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
	IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney
to be executed as of this 1st day of August, 2022.

					/s/ Eric Cribbs
					Eric Cribbs